MedTrace Logo

Removal of the Evolution® Esophageal Stent - Fully Covered

NCT01900691 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2022-09-13

Study results available
· View outcomes & findings →

Summary

The CLARITY study is a clinical trial approved by US FDA to study the removal of the Evolution® Esophageal Stent-Fully Covered in malignant and benign indications.

Conditions

  • Esophageal Fistula
  • Esophageal Neoplasms
  • Esophageal Perforation
  • Esophageal Stenosis
  • Stents

Interventions

DEVICE

Evolution® Esophageal Stent - Fully Covered

Placement of the Evolution® Esophageal Stent for benign or malignant strictures, fistulas, perforations or leaks with the intention of removal

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Principal Investigators

  • John Vargo, M.D., M.P.H. · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2018-12-10
Completion
2018-12-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01900691 on ClinicalTrials.gov